AcouSort AB (ACOU) - Total Liabilities

Latest as of September 2025: Skr3.21 Million SEK ≈ $345.34K USD

Based on the latest financial reports, AcouSort AB (ACOU) has total liabilities worth Skr3.21 Million SEK (≈ $345.34K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

AcouSort AB - Total Liabilities Trend (2013–2024)

This chart illustrates how AcouSort AB's total liabilities have evolved over time, based on quarterly financial data. See ACOU current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

AcouSort AB Competitors by Total Liabilities

The table below lists competitors of AcouSort AB ranked by their total liabilities.

Company Country Total Liabilities
Metalsgrove Mining Ltd
AU:MGA
Australia AU$123.69K
Alice QUEEN Ltd
AU:AQX
Australia AU$1.48 Million
Nvni Group Limited Ordinary Shares
NASDAQ:NVNI
USA $517.01 Million
RS Public Company Limited
BK:RS
Thailand ฿5.35 Billion
Dynaciate Group Bhd
KLSE:5178
Malaysia RM65.76 Million
Cahayaputra Asa Keramik Tbk PT
JK:CAKK
Indonesia Rp326.94 Billion
ESSA Pharma Inc
NASDAQ:EPIX
USA $1.60 Million
Viking Mines Ltd
AU:VKA
Australia AU$370.98K

Liability Composition Analysis (2013–2024)

This chart breaks down AcouSort AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of AcouSort AB.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AcouSort AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AcouSort AB (2013–2024)

The table below shows the annual total liabilities of AcouSort AB from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 Skr3.86 Million
≈ $415.51K
-62.80%
2023-12-31 Skr10.38 Million
≈ $1.12 Million
-53.96%
2022-12-31 Skr22.54 Million
≈ $2.43 Million
+537.14%
2021-12-31 Skr3.54 Million
≈ $380.75K
-1.15%
2020-12-31 Skr3.58 Million
≈ $385.16K
+69.38%
2019-12-31 Skr2.11 Million
≈ $227.39K
+13.60%
2018-12-31 Skr1.86 Million
≈ $200.17K
+74.81%
2017-12-31 Skr1.06 Million
≈ $114.50K
-48.94%
2016-12-31 Skr2.08 Million
≈ $224.27K
+1044.60%
2015-12-31 Skr182.07K
≈ $19.59K
-66.51%
2014-12-31 Skr543.60K
≈ $58.50K
-74.88%
2013-12-31 Skr2.16 Million
≈ $232.88K
--

About AcouSort AB

ST:ACOU Sweden Biotechnology
Market Cap
$9.52 Million
Skr88.47 Million SEK
Market Cap Rank
#27158 Global
#593 in Sweden
Share Price
Skr4.18
Change (1 day)
-1.42%
52-Week Range
Skr2.13 - Skr4.99
All Time High
Skr31.61
About

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC … Read more